SEC Contract Filing

Filing Date: 2022-02-24

Document Content:
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>brhc10034373_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html>
 <head>
 <title></title>
 <!-- Licensed to: Broadridge Financial Solutions, Inc
 Document created using EDGARfilings PROfile 8.1.1.0
 Copyright 1995 - 2022 Broadridge -->
 </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
 <font style="font-family: 'Times New Roman'; font-size: 10pt;"> </font>
 <div>
 <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
 <div>
 <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: right;">Exhibit 10.1<br>
 </div>
 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
 </div>
 <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">TERMINATION AGREEMENT</div>
 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
 </div>
 <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This TERMINATION AGREEMENT (the &#8220;<u>Agreement</u>&#8221;), dated as of February 23, 2022, is made by and between ARYA Sciences Acquisition Corp IV (&#8220;<u>ARYA</u>&#8221;)

 and Amicus Therapeutics, Inc. (the &#8220;<u>Company</u>&#8221;).</div>
 <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
 <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">W I T N E S E T H:</div>
 <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
 <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">, ARYA and the Company entered into that certain Business Combination Agreement, dated as of September 29, 2021 (the &#8220;<u>Combination Agreement</u>&#8221;), by and among ARYA, the Company, Amicus GT Holdings, LLC and Caritas
 Therapeutics, LLC.&#160; Each capitalized term used but not defined herein has the meaning given to it in the Combination Agreement.</font></div>
 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
 </div>
 <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">, the Closing has not occurred as of the date of this Agreement and ARYA and the Company wish to terminate the Combination Agreement and the Additional Agreements that have been executed as of the date hereof, subject to
 the terms and conditions set forth herein.</font></div>
 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
 </div>
 <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">NOW, THEREFORE</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">, in consideration of the premises set forth above, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the Parties
 accordingly agree as follows:</font></div>
 <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
 <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Section 1.</u></font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In accordance with
 <u>Section 9.1(a)</u> (Termination) and <u>Section 9.2</u> (Effect of Termination) of the Combination Agreement and subject to the terms set forth in this Agreement, ARYA and the Company hereby mutually agree to terminate the Combination
 Agreement effective as of the date of this Agreement.</font></div>
 <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
 <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Section 2.</u></font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As a consequence of
 termination of the Combination Agreement, effective as of the date of this Agreement, the entire Combination Agreement and any Additional Agreements that have been executed as of the date hereof shall become void (and there shall be no Liability
 or obligation on the part of the Parties and their respective Representatives) with the exception of, (a) in the case of the Combination Agreement, <u>Section 6.5(a)</u> (Confidentiality; Access to Information), <u>Section 9.2</u>, <u>Article
 XI</u> (Miscellaneous) and <u>Article I</u> (Definitions) (to the extent related to the foregoing), each of which shall survive such termination and remain valid and binding obligations of the Parties in accordance with their terms, (b) in the
 case of the Sponsor Letter Agreement, in accordance with Section 6(i) and Section 6(iii) of the Sponsor Letter Agreement and (c) the Confidentiality Agreement, which shall survive such termination and remain a valid and binding obligation of the
 parties thereto in accordance with its terms.</font></div>
 <div style="text-align: left; text-indent: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"> <br>
 </font></div>
 <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
 <div id="DSPFPageBreak" style="page-break-after:always;">
 <hr nos